Page last updated: 2024-08-22

n-methylaspartate and ly 233053

n-methylaspartate has been researched along with ly 233053 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arnold, MB; Deeter, JB; Jones, ND; Leander, JD; Lodge, D; Ornstein, PL; Schoepp, DD1
Clark, WM; Kochhar, A; Madden, KP; Zivin, JA1
Leander, JD; Lodge, D; Ornstein, PL; Salhoff, CR; Schoepp, DD; Zeman, S; Zimmerman, DM1
Leander, JD; Lodge, D; Ornstein, PL; Schoepp, DD; Wong, T; Zimmerman, DM1
Clark, WM; Madden, KP; Zivin, JA1

Other Studies

5 other study(ies) available for n-methylaspartate and ly 233053

ArticleYear
NMDA antagonist activity of (+/-)-(2SR,4RS)-4-(1H-tetrazol-5-ylmethyl)piperidine-2-carboxylic acid resides with the (-)-2R,4S-isomer.
    Journal of medicinal chemistry, 1992, Aug-21, Volume: 35, Issue:17

    Topics: Animals; Animals, Newborn; Corpus Striatum; Mice; Molecular Structure; N-Methylaspartate; Nerve Degeneration; Pipecolic Acids; Rats; Receptors, N-Methyl-D-Aspartate; Seizures; Stereoisomerism; Structure-Activity Relationship; Tetrazoles; X-Ray Diffraction

1992
Efficacy of LY233053, a competitive glutamate antagonist, in experimental central nervous system ischemia.
    Journal of neurosurgery, 1992, Volume: 76, Issue:1

    Topics: Animals; Brain Ischemia; Dose-Response Relationship, Drug; Ischemia; N-Methylaspartate; Pipecolic Acids; Rabbits; Spinal Cord; Tetrazoles

1992
Pharmacological characterization of LY233053: a structurally novel tetrazole-substituted competitive N-methyl-D-aspartic acid antagonist with a short duration of action.
    The Journal of pharmacology and experimental therapeutics, 1990, Volume: 255, Issue:3

    Topics: Administration, Oral; Animals; Animals, Newborn; Behavior, Animal; Binding, Competitive; Dose-Response Relationship, Drug; Electroshock; Female; Injections, Intraperitoneal; Male; N-Methylaspartate; Pipecolic Acids; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Seizures; Tetrazoles; Tritium

1990
LY233053: a structurally novel, potent and selective competitive N-methyl-D-aspartate receptor antagonist.
    Progress in clinical and biological research, 1990, Volume: 361

    Topics: Animals; Binding, Competitive; Brain; Dose-Response Relationship, Drug; Kinetics; Mice; N-Methylaspartate; Neurons; Pipecolic Acids; Rats; Receptors, N-Methyl-D-Aspartate; Seizures; Tetrazoles

1990
Delayed therapy of experimental ischemia with competitive N-methyl-D-aspartate antagonists in rabbits.
    Stroke, 1993, Volume: 24, Issue:7

    Topics: Animals; Ischemia; N-Methylaspartate; Paraplegia; Pipecolic Acids; Rabbits; Receptors, N-Methyl-D-Aspartate; Spinal Cord; Tetrazoles; Time Factors

1993